DOIAbstract
We report the clinical experience gained with interferon treatment of B and T cell neoplasms, as well as of myeloproliferative and myelodysplastic syndrome
We report the clinical experience gained with interferon treatment of B and T cell neoplasms, as well as of myeloproliferative and myelodysplastic syndrome
Thirty patients affected by previously untreated high risk myelodysplastic syndromes (MDS) were trea...
Many randomized trials have evaluated alpha-interferon as myeloma therapy, some suggesting a benefit...
We have administered interferon alfa-2b, alone or in combination with chemotherapy, to 126 Ph1-posit...
Myeloid malignancies are a heterogeneous group of clonal haematopoietic disorders, caused by abnorma...
Contains fulltext : mmubn000001_101473001.pdf (publisher's version ) (Open Access)...
The interferons are cytokines with a wide array of biological properties. In hematological malignanc...
Multiple myeloma is one of the common hema-tologic malignancies now affecting approxi-mately 12 500 ...
The therapeutic efficacy of interferon-alpha (IFN-α) in the treatment of chronic myeloid leukemia is...
2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and were treated w...
The classical myeloproliferative neoplasms (MPN) are uncommon clonal haemopoietic malignancies chara...
Forty-two patients with multiple myeloma were allocated to two groups to receive either polychemothe...
Interferon treatment has been shown to cause myelosuppression in man and in a mouse model. Combinati...
The classical myeloproliferative neoplasms (MPN) are uncommon clonal haemopoietic malignancies chara...
Phase I, II, and III trials that defined the thera-peutic effectiveness of interferons for neoplasti...
Impairment in marrow function often characterizes the evolution of myelodysplastic syndrome. As a di...
Thirty patients affected by previously untreated high risk myelodysplastic syndromes (MDS) were trea...
Many randomized trials have evaluated alpha-interferon as myeloma therapy, some suggesting a benefit...
We have administered interferon alfa-2b, alone or in combination with chemotherapy, to 126 Ph1-posit...
Myeloid malignancies are a heterogeneous group of clonal haematopoietic disorders, caused by abnorma...
Contains fulltext : mmubn000001_101473001.pdf (publisher's version ) (Open Access)...
The interferons are cytokines with a wide array of biological properties. In hematological malignanc...
Multiple myeloma is one of the common hema-tologic malignancies now affecting approxi-mately 12 500 ...
The therapeutic efficacy of interferon-alpha (IFN-α) in the treatment of chronic myeloid leukemia is...
2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and were treated w...
The classical myeloproliferative neoplasms (MPN) are uncommon clonal haemopoietic malignancies chara...
Forty-two patients with multiple myeloma were allocated to two groups to receive either polychemothe...
Interferon treatment has been shown to cause myelosuppression in man and in a mouse model. Combinati...
The classical myeloproliferative neoplasms (MPN) are uncommon clonal haemopoietic malignancies chara...
Phase I, II, and III trials that defined the thera-peutic effectiveness of interferons for neoplasti...
Impairment in marrow function often characterizes the evolution of myelodysplastic syndrome. As a di...
Thirty patients affected by previously untreated high risk myelodysplastic syndromes (MDS) were trea...
Many randomized trials have evaluated alpha-interferon as myeloma therapy, some suggesting a benefit...
We have administered interferon alfa-2b, alone or in combination with chemotherapy, to 126 Ph1-posit...
Add to ORKG